DH Holds Meeting with New Head of Secretariat of WHO Framework Convention on Tobacco Control

DH holds meeting with new Head of Secretariat of WHO Framework Convention on Tobacco Control to deepen collaboration and exchanges on tobacco control

The Director of Health, Dr Ronald Lam, yesterday (September 25) met with the new Head of the Secretariat of the World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC), Mr Andrew Black, for an in-depth exchange on tobacco control work.

Mr Black assumed office as the Head of the Secretariat of the WHO FCTC on August 1 this year. Dr Lam welcomed Mr Black and expressed appreciation for his taking time out of a busy schedule to visit the Department of Health (DH) of the Hong Kong Special Administrative Region (HKSAR) to exchange views on the latest progress and strategies in tobacco control work.

Dr Lam said, "We are very honoured to receive Mr Black and representatives of the Southeast Asia Tobacco Control Alliance (SEATCA). The HKSAR Government has been advancing tobacco control through a science-based, public-oriented, multi-pronged and progressive approach. The HKSAR Government's strategy in tackling alternative smoking products (ASPs), including e-cigarettes, heated tobacco products and herbal cigarettes, is to nip the problem in the bud, by preventing ASPs from taking root in Hong Kong, and tackling at source the use of ASPs for drug inhalation. To this end, the HKSAR Government banned the import, manufacture, promotion and sale of ASPs, as well as the possession of ASPs for commercial purposes, more than four years ago. To further strengthen the control of ASPs, the Government has, since April 30 this year, prohibited the possession of ASPs in public places to prevent their local circulation in any form and to further prevent the younger generation from becoming addicted to smoking."

"Hong Kong's tobacco control journey is the culmination of decades of concerted efforts to build a comprehensive tobacco control strategy through multi-pronged measures. Adopting a whole-of-society approach, the Government has successfully lowered our smoking prevalence to 8.5 per cent in 2025, which is among the lowest in the world. The HKSAR Government will continue to implement the '10 measures for tobacco control'. The full implementation of plain packaging requirement and the duty stamp system for conventional smoking products will be completed by the end of next year. The relevant subsidiary legislation was gazetted on September 11. Following the implementation of these two measures, the Government will proceed with implementation of a ban on flavoured smoking products," Dr Lam added.

Mr Black noted that Hong Kong's tobacco control policies have long been closely aligned with the FCTC, and gave high recognition to Hong Kong's efforts and achievements in tobacco control. He specifically pointed out that Hong Kong's experience is highly valuable as a reference for other jurisdictions. He expressed strong support for Hong Kong's forthcoming measures, including plain packaging requirement for conventional smoking products, the duty stamp system and a ban on flavoured smoking products.

In addition, Mr Black commended the contribution made by the DH as a WHO Collaborating Centre on Smoking Cessation and Treatment of Tobacco Dependence. The DH has, since 2012, regularly provided training for tobacco control personnel in the Western Pacific Region. It also regularly organises training on smoking cessation treatment and Chinese medicine acupuncture for smoking cessation services for the Chinese Mainland, Hong Kong and Macao, serving as a regional hub in tobacco control and smoking cessation.

The Executive Director of SEATCA, Dr Ulysses Dorotheo; Programme Manager of SEATCA, Ms Irene Reyes; Professor and Director of the Primary Health Care Academy of the University of Hong Kong, Professor Sophia Chan; the Controller of Regulatory Affairs of the DH, Dr Fung Ying; and the Head of the Tobacco and Alcohol Control Office of the DH, Dr Manny Lam, also attended the meeting.

The Director of Health, Dr Ronald Lam, yesterday (September 25) met with the new Head of the Secretariat of the World Health Organization Framework Convention on Tobacco Control, Mr Andrew Black, for an in-depth exchange on tobacco control work. Photo shows Dr Lam (front row, centre); Mr Black (front row, second left); the Executive Director of the Southeast Asia Tobacco Control Alliance, Dr Ulysses Dorotheo (front row, second right); Professor and Director of HKU Primary Health Care Academy, Professor Sophia Chan (front row, first left); Controller, Regulatory Affairs of the Department of Health, Dr Fung Ying (front row, first right); Head of Tobacco and Alcohol Control Office of the DH, Dr Manny Lam (second row, second left); and other participants of the meeting. Source: HKSAR Government Press Releases

The Director of Health, Dr Ronald Lam (second left), yesterday (September 25) met with the new Head of the Secretariat of the World Health Organization Framework Convention on Tobacco Control, Mr Andrew Black (second right), for an in-depth exchange on tobacco control work. Source: HKSAR Government Press Releases

DH clarifies COVID-19 vaccination arrangements

In response to comments from a medical organisation about a lack of stock of COVID-19 vaccines and concerns about low COVID-19 vaccination rates, as well as related media enquiries, the Centre for Health Protection (CHP) of the Department of Health (DH) today (November 11) issued the following clarification:

Scientific evidence shows that COVID-19 vaccines are effective in reducing the risk of severe disease and death. Following the recommendations of the World Health Organization, and the Scientific Committee on Vaccine Preventable Diseases and the Scientific Committee on Emerging and Zoonotic Diseases(Joint Scientific Committee) under the CHP, the CHP has continuously encouraged the public to receive the vaccine at appropriate times to minimise the risk of severe disease and death after being infected by COVID-19. Thanks to the government's and relevant sectors' continuous efforts to promote vaccination, the uptake rate of the initial doses of COVID-19 vaccine in Hong Kong exceeds 90 per cent, which is considered high internationally.

Regarding COVID-19 booster vaccination, the Joint Scientific Committee recommended them only for high-risk priority groups. Besides, one must receive a vaccine booster at least 180 days after their last dose or COVID-19 infection (whichever is later). Therefore, the vaccination rate is expected to be relatively low. Due to reinfection or vaccination, many people infected with COVID-19 experience milder symptoms and chose not to seek medical care. The Government faces limitations in collecting and reviewing the latest infection figures. As a result, the actual vaccination rates for high-risk priority groups cannot be accurately determined.

The CHP previously announced that the shelf life of the LP.8.1 vaccine for children and adults would expire in mid-July and early September of this year respectively, and that the production and shipment of COVID-19 vaccines containing new ingredients would take time. Starting October 29, the CHP has been providing the Spikevax XFG mRNA vaccine to childrenaged 6 months to 11 years. The first shipment of the new batch of Spikevax XFG vaccine for individuals aged 12 or above is expected to arrive in Hong Kong next month (December). By then, market supply will resume and private doctors will be able to order from pharmaceutical companies as usual. During this transitional period while awaiting vaccine production and delivery, the absence of COVID-19 vaccinations for adults is normal and temporary.

Regarding COVID-19 vaccination venues, the mRNA COVID-19 vaccines currently in use require complex cold-chain handling and have a limited shelf life after thawing. To provide convenience to the public, minimise vaccine wastage and ensure vaccine efficacy, the Government has set up a total of 75 COVID-19 vaccination venues across Hong Kong, including Specialist Out-patient Clinics (SOPCs) and Family Medicine Clinics (FMCs) in public hospitals, private clinics, Maternal and Child Health Centres, etc. Given that patients co-infected with seasonal influenza and COVID-19 are at a higher risk of severe complications and death, the CHP all along recommends that priority groups receive both seasonal influenza vaccination and COVID-19 vaccination booster to reduce the risk of serious illness and death.Eligible persons can receive both COVID-19 and influenza vaccinations at all current COVID-19 vaccination venues, including SOPCs and FMCs of the concerned public hospitals, as well as private clinics. Therefore, the CHP considers that there is currently no need to further expand the number of COVID-19 vaccination venues.

According to a survey conducted by the medical organisation concerned, nearly 40 per cent of the doctors surveyed do not proactively remind patients to receive COVID-19 vaccination. The CHP expressed concern about this and urged healthcare professionals to proactively remind patients of the importance of receiving COVID-19 vaccination in a timely manner. Even if their clinics do not provide vaccination services, healthcare professionals can still provide patients with information about the Government's COVID-19 Vaccination Programme to help safeguard public health.

The CHP will continue to strengthen publicity and education efforts through various online and offline channels to encourage priority groups to receive COVID-19 vaccination as soon as possible once the COVID-19 vaccines for persons aged 12 or above is available.

For more information about the COVID-19 Vaccination Programme, please visit the CHP's website.

Source: AI-found images